(Q40624932)

22 September 2017

1 reference

title

Clinical pharmacokinetics and pharmacodynamics of carvedilol (English)

1 reference

22 September 2017

1 reference

1 reference

T Morgan

1

1 reference

22 September 2017

1 May 1994

1 reference

Clinical Pharmacokinetics

22 September 2017

1 reference

22 September 2017

26

1 reference

22 September 2017

5

1 reference

22 September 2017

335-346

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199426050-00002

22 September 2017

0 references

cites work

Circadian antihypertensive profile of carvedilol (BM 14190)

1 reference

12 December 2020

Effects of carvedilol in patients with impaired left ventricular function due to ischaemic heart disease

1 reference

12 December 2020

Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation

1 reference

12 December 2020

High-performance liquid chromatographic method for the determination of carvedilol and its desmethyl metabolite in body fluids

1 reference

12 December 2020

Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide

1 reference

12 December 2020

Blood-pressure-lowering effect of carvedilol vs nitrendipine in geriatric hypertensives

1 reference

12 December 2020

Value of carvedilol in congestive heart failure secondary to coronary artery disease.

1 reference

12 December 2020

Influence of carvedilol and propranolol on coronary blood flow.

1 reference

12 December 2020

Pharmacological characteristics of the stereoisomers of carvedilol

1 reference

12 December 2020

Chronic haemodynamic effects of carvedilol in essential hypertension at rest and during exercise

1 reference

12 December 2020

Carvedilol for systemic hypertension

1 reference

12 December 2020

A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group

1 reference

12 December 2020

Effects of carvedilol on serum lipids in patients with essential hypertension

1 reference

12 December 2020

Liquid chromatographic assay and disposition of carvedilol in healthy volunteers

1 reference

12 December 2020

Metabolism of carvedilol in man

1 reference

12 December 2020

Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension

1 reference

12 December 2020

Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity

1 reference

12 December 2020

Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension

1 reference

12 December 2020

Influence of carvedilol on blood glucose and glycohaemoglobin A1 in non-insulin-dependent diabetics

1 reference

12 December 2020

In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol

1 reference

12 December 2020

Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker

1 reference

12 December 2020

Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris

1 reference

12 December 2020

Clinical pharmacology of carvedilol in normal volunteers

1 reference

12 December 2020

The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension

1 reference

12 December 2020

Dose-effect relationship of carvedilol in essential hypertension. An open study

1 reference

12 December 2020

Pharmacokinetics of carvedilol in older and younger patients

1 reference

12 December 2020

Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension

1 reference

12 December 2020

Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound

1 reference

12 December 2020

Comparison and interaction of low dose felodipine and enalapril in the treatment of essential hypertension in elderly subjects

1 reference

12 December 2020

Pharmacokinetic and blood pressure effects of carvedilol in patients with chronic renal failure

1 reference

12 December 2020

A pharmacokinetic study of carvedilol (BM 14.190) in elderly subjects: preliminary report

1 reference

12 December 2020

Vasodilatory effects of carvedilol and pindolol.

1 reference

12 December 2020

Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol

1 reference

12 December 2020

Assay and disposition of carvedilol enantiomers in humans and monkeys: evidence of stereoselective presystemic metabolism

1 reference

12 December 2020

Effect of carvedilol on left ventricular function and mass in hypertension

1 reference

12 December 2020

The safety of adding carvedilol to hypertensive patients inadequately treated with diuretics

1 reference

12 December 2020

Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients

1 reference

12 December 2020

Response rate with respect to the blood pressure-lowering effect of the vasodilating and beta-blocking agent carvedilol

1 reference

12 December 2020

Pharmacokinetics and disposition of carvedilol in humans

1 reference

12 December 2020

Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol

1 reference

12 December 2020

Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance

1 reference

12 December 2020

Effects of carvedilol on cerebral blood flow and its autoregulation in previous stroke patients with hypertension

1 reference

12 December 2020

Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

The use of carvedilol in elderly hypertensive patients.

1 reference

12 December 2020

Effects of carvedilol on ventricular arrhythmias

1 reference

12 December 2020

Hemodynamic and metabolic effects of carvedilol: a meta-analysis approach

1 reference

12 December 2020

Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients

1 reference

12 December 2020

Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study

1 reference

12 December 2020

Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Acute haemodynamic effects of carvedilol in essential hypertension at rest and during exercise

1 reference

12 December 2020

Effectiveness of blood pressure control with once daily administration of enalapril and perindopril

1 reference

12 December 2020

Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension

1 reference

12 December 2020

Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol

1 reference

12 December 2020

Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide

1 reference

12 December 2020

Carvedilol increases the systemic bioavailability of oral digoxin

1 reference

12 December 2020

Effects of carvedilol on serum lipids in hypertensive and normotensive subjects

1 reference

12 December 2020

10.2165/00003088-199426050-00002

Identifiers

DOI

1 reference

PubMed ID

7914479

Dimensions Publication ID

22 September 2017

0 references

1 reference

PubMed ID

7914479